Merit Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History

Merit Financial Group’s Portfolio APLS Stock Details APLS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$442K	Sell
2025 Q2	$365K	Sell
2025 Q1	$738K	Buy
2024 Q4	$254K	Buy